REward Processing And Citalopram Study
NCT06017037
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Anhedonia
Interventions
DRUG:
Citalopram 20mg
DRUG:
Placebo
Sponsor
University of Oxford